IES20140280A2 - Human targets II - Google Patents

Human targets II

Info

Publication number
IES20140280A2
IES20140280A2 IES20140280A IES20140280A IES20140280A2 IE S20140280 A2 IES20140280 A2 IE S20140280A2 IE S20140280 A IES20140280 A IE S20140280A IE S20140280 A IES20140280 A IE S20140280A IE S20140280 A2 IES20140280 A2 IE S20140280A2
Authority
IE
Ireland
Prior art keywords
human targets
toi
targets
human
interest
Prior art date
Application number
IES20140280A
Inventor
Jasper Clube
Original Assignee
Kymab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB1322250.0A external-priority patent/GB2521355A/en
Priority claimed from GB1322253.4A external-priority patent/GB2521356B/en
Priority claimed from US14/138,446 external-priority patent/US8883157B1/en
Priority claimed from EP14172579.6A external-priority patent/EP2886558A1/en
Priority claimed from US14/331,730 external-priority patent/US9914769B2/en
Priority claimed from US14/331,609 external-priority patent/US9051378B1/en
Priority claimed from US14/331,665 external-priority patent/US9023359B1/en
Priority claimed from US14/457,536 external-priority patent/US9017678B1/en
Priority claimed from US14/457,566 external-priority patent/US8945560B1/en
Priority claimed from US14/472,698 external-priority patent/US8986694B1/en
Priority claimed from US14/472,818 external-priority patent/US8980273B1/en
Priority claimed from US14/472,685 external-priority patent/US8992927B1/en
Priority claimed from US14/472,828 external-priority patent/US8986691B1/en
Priority claimed from EP14185297.0A external-priority patent/EP2975058A1/en
Priority claimed from US14/500,233 external-priority patent/US9045548B1/en
Priority claimed from US14/507,368 external-priority patent/US9034332B1/en
Application filed by Kymab Ltd filed Critical Kymab Ltd
Publication of IES20140280A2 publication Critical patent/IES20140280A2/en
Publication of IES86602B2 publication Critical patent/IES86602B2/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Physical Vapour Deposition (AREA)

Abstract

The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
IES20140280A 2013-12-17 2014-11-07 An injectable antibody preparation for use in reducing or maintaining previously reduced cholesterol level IES86602B2 (en)

Applications Claiming Priority (25)

Application Number Priority Date Filing Date Title
US201361916866P 2013-12-17 2013-12-17
US201361916862P 2013-12-17 2013-12-17
GB1322253.4A GB2521356B (en) 2013-12-17 2013-12-17 Antibodies for use in treating conditions related to specific PCKS9 variants and associated diagnostic methods
GB1322250.0A GB2521355A (en) 2013-12-17 2013-12-17 Human targets I
US14/138,446 US8883157B1 (en) 2013-12-17 2013-12-23 Targeting rare human PCSK9 variants for cholesterol treatment
US14/228,760 US8951523B1 (en) 2013-12-17 2014-03-28 Targeting rare human PCSK9 variants for cholesterol treatment
EP14172579.6A EP2886558A1 (en) 2013-12-17 2014-06-16 Antibodies for use in treating conditions related to specific PCSK9 variants in specific patient populations
EP14172578.8A EP2886557A1 (en) 2013-12-17 2014-06-16 Antibodies for use in treating conditions related to specific PCSK9 variants in specific patient populations
US14/331,665 US9023359B1 (en) 2014-07-15 2014-07-15 Targeting rare human PCSK9 variants for cholesterol treatment
US14/331,730 US9914769B2 (en) 2014-07-15 2014-07-15 Precision medicine for cholesterol treatment
US14/331,609 US9051378B1 (en) 2014-07-15 2014-07-15 Targeting rare human PCSK9 variants for cholesterol treatment
US14/457,566 US8945560B1 (en) 2014-07-15 2014-08-12 Method of treating rheumatoid arthritis using antibody to IL6R
US14/457,536 US9017678B1 (en) 2014-07-15 2014-08-12 Method of treating rheumatoid arthritis using antibody to IL6R
US14/472,818 US8980273B1 (en) 2014-07-15 2014-08-29 Method of treating atopic dermatitis or asthma using antibody to IL4RA
US14/472,685 US8992927B1 (en) 2014-07-15 2014-08-29 Targeting human NAV1.7 variants for treatment of pain
US14/472,698 US8986694B1 (en) 2014-07-15 2014-08-29 Targeting human nav1.7 variants for treatment of pain
US14/472,828 US8986691B1 (en) 2014-07-15 2014-08-29 Method of treating atopic dermatitis or asthma using antibody to IL4RA
US14/490,112 US9034331B1 (en) 2014-07-15 2014-09-18 Targeting rare human PCSK9 variants for cholesterol treatment
EP14185297.0A EP2975058A1 (en) 2014-07-15 2014-09-18 Antibodies for use in treating conditions related to specific PCSK9 variants in specific patient populations
US14/490,175 US9040052B1 (en) 2013-12-17 2014-09-18 Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatment
US14/490,091 US9068012B1 (en) 2014-07-15 2014-09-18 Targeting rare human PCSK9 variants for cholesterol treatment
US14/490,160 US8999341B1 (en) 2014-07-15 2014-09-18 Targeting rare human PCSK9 variants for cholesterol treatment
US14/500,233 US9045548B1 (en) 2014-07-15 2014-09-29 Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatment
US14/500,397 US10618971B2 (en) 2013-12-17 2014-09-29 Targeting rare human PCSK9 variants for cholesterol treatment
US14/507,368 US9034332B1 (en) 2014-07-15 2014-10-06 Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment

Publications (2)

Publication Number Publication Date
IES20140280A2 true IES20140280A2 (en) 2015-06-17
IES86602B2 IES86602B2 (en) 2015-11-18

Family

ID=53398263

Family Applications (2)

Application Number Title Priority Date Filing Date
IES20140280A IES86602B2 (en) 2013-12-17 2014-11-07 An injectable antibody preparation for use in reducing or maintaining previously reduced cholesterol level
IES20140279A IES86601B2 (en) 2013-12-17 2014-11-07 An injectable antibody preparation for use in reducing or maintaining previously reduced cholesterol level

Family Applications After (1)

Application Number Title Priority Date Filing Date
IES20140279A IES86601B2 (en) 2013-12-17 2014-11-07 An injectable antibody preparation for use in reducing or maintaining previously reduced cholesterol level

Country Status (1)

Country Link
IE (2) IES86602B2 (en)

Also Published As

Publication number Publication date
IES86602B2 (en) 2015-11-18
IES86601B2 (en) 2015-11-18
IES20140279A2 (en) 2015-06-17

Similar Documents

Publication Publication Date Title
ZA202004557B (en) Modulatory polynucleotides
IL286103B (en) Methods related to crispr–cas, compositions and components for cancer immunotherapy
WO2015092393A3 (en) Ligands specifically binding to human targets of interest
AU2015287674B2 (en) Topical antiviral compositions and methods of using the same
PH12016501763B1 (en) Multispecific antibodies
MX2016003843A (en) Irak inhibitors and uses thereof.
PH12017501077A1 (en) Compositions and methods for antibodies targeting bmp6
MX391052B (en) Htt repressors and uses thereof
MX2015008999A (en) Mk2 inhibitors and uses thereof.
SG10201902326XA (en) Mk2 inhibitors and uses thereof
IN2015DN00127A (en)
EP3258966A4 (en) Methods, compositions, and kits for treatment of cancer
MX2020001756A (en) Benzoquinolone inhibitors of vmat2.
PH12015501059A1 (en) Anti-hemagglutinin antibodies and methods of use
EP3200582A4 (en) Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
MX2018000715A (en) Methods for treating cancer using apilimod.
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
CY1120759T1 (en) PREPARATION OF DIGLYCOSITE (S, S) -SECOCOSOLARICIRESINOL AND DIGLYCOSITE (R, R) -SECOSOSOLARICIRESINOL
CL2016000351A1 (en) Method for quantification of actinium-227 in radio-223 compositions.
IN2013MU00848A (en)
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
IN2013MU03641A (en)
MX2016003207A (en) Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation.
MX2015016603A (en) Corticosteroid compositions.
EP3089745A4 (en) Compounds, compositions, and methods for the treatment of cancers

Legal Events

Date Code Title Description
MK9A Patent expired